XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
-0.02 (-0.62%)
At close: Aug 21, 2025, 3:59 PM
3.20
0.00%
After-hours: Aug 21, 2025, 04:10 PM EDT

XBiotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
152.94M 155.9M 172.68M 183.12M 188.53M 201.04M 200.02M 202.19M 143.39M 152.48M 157.31M 160.57M 225.79M 231.82M 236.98M 238.88M 315.26M 239.88M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a 61.38M 60.18M 60.17M 59.53M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a -25.62M n/a -1.66M n/a n/a n/a -1.09M n/a n/a n/a
Receivables
638K 638K 858K 871K 993K 945K 935K 1.33M 3.79M 2.92M 1.76M 2.71M 12.43M 10.53M 8.95M 10.44M 8.13M 1.69M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -62.24M n/a n/a -8.95M n/a n/a n/a
Other Current Assets
1.31M 1.15M 1.03M 1.04M 1.12M 1.07M 760K 879K 947K 703K 601K n/a n/a n/a n/a 544K 1.09M 86.04M
Total Current Assets
154.89M 157.69M 174.57M 185.03M 190.64M 203.06M 201.72M 204.4M 209.51M 216.28M 219.84M 223.43M 238.76M 242.98M 246.87M 250.24M 324.86M 327.9M
Property-Plant & Equipment
23.79M 24.18M 24.53M 24.82M 24.92M 24.8M 24.9M 25.2M 25.62M 25.84M 26.26M 26.64M 27.28M 27.82M 28.31M 28.64M 28.45M 27.51M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
23.79M 24.18M 24.53M 24.82M 24.92M 24.8M 25.52M 25.2M 25.62M 25.84M 26.26M 27.41M 27.7M 27.82M 28.31M 29.28M 29.09M 28.04M
Total Assets
178.68M 181.86M 199.09M 209.85M 215.56M 227.86M 226.62M 229.6M 235.14M 242.12M 246.1M 250.83M 266.46M 270.8M 275.18M 279.52M 353.96M 355.94M
Account Payables
1.43M 1.1M 2.22M 1.51M 1.7M 2.61M 2.52M 1.47M 1.82M 1.36M 2.41M 1.38M 2.45M 1.32M 2.07M 1.01M 1.49M 1.24M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 10.25M 10M 10M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a 611K n/a n/a n/a 562K n/a n/a n/a 1.17M n/a n/a n/a 904K 1.21M 719K n/a
Total Current Liabilities
3.86M 5.41M 15.11M 15.99M 17.14M 16.88M 6.1M 5.29M 4.45M 3.62M 4.07M 3.58M 8.23M 2.89M 3.45M 3.86M 3.89M 2.72M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.76M 1.74M 1.72M 1.74M 1.72M 1.69M 1.67M 1.65M 1.62M 1.6M 1.58M 1.57M 1.56M 1.48M 1.47M 1.39M 1.39M 1.12M
Total Long-Term Liabilities
1.76M 1.74M 1.72M 1.74M 1.72M 1.69M 1.67M 1.65M 1.62M 1.6M 1.64M 2.45M 2.43M 2.35M 2.34M 1.5M 1.5M 1.12M
Total Liabilities
5.62M 7.15M 16.82M 17.74M 18.85M 18.58M 7.77M 6.94M 6.07M 5.22M 5.7M 6.03M 10.67M 5.24M 5.79M 5.36M 5.39M 3.84M
Total Debt
n/a n/a 10.25M 10M 10M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
276.54M 276.43M 273.11M 272.44M 272.01M 271.59M 271.15M 269.89M 268.93M 268.03M 267.32M 266.29M 265.16M 263.71M 262.26M 260.88M 256.78M 255.51M
Retained Earnings
-103.48M -101.72M -90.84M -80.33M -75.31M -62.31M -52.31M -47.67M -40.31M -31.57M -27.75M -24.55M -11.89M -244K 5.15M 11.62M 89.88M 95M
Comprehensive Income
n/a n/a n/a n/a n/a -0.00 0.00 440K 440K 440K 826K 3.07M 2.52M 2.09M 1.97M 1.66M 1.9M 1.58M
Shareholders Equity
173.06M 174.71M 182.27M 192.12M 196.7M 209.28M 218.85M 222.66M 229.06M 236.91M 240.4M 244.81M 255.79M 265.56M 269.38M 274.16M 348.56M 352.1M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a 61.38M 60.18M 60.17M 59.53M n/a n/a n/a n/a n/a n/a